4-Nitroacetophenone-derived thiosemicarbazones and their copper(II) complexes with significant in vitro anti-trypanosomal activity

N 4-Methyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4M, 1), N 4, N 4-dimethyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4DM, 2) and N 4-piperidyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4Pip, 3) and their copper(II) complexes [Cu(4NO 2Ac4M) 2] ( 4), [Cu(4NO 2Ac4DM) 2] ( 5) and [Cu(...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 43; no. 5; pp. 939 - 948
Main Authors Pérez-Rebolledo, Anayive, Teixeira, Letícia R., Batista, Alzir A., Mangrich, Antonio S., Aguirre, Gabriela, Cerecetto, Hugo, González, Mercedes, Hernández, Paola, Ferreira, Ana M., Speziali, Nivaldo L., Beraldo, Heloisa
Format Journal Article
LanguageEnglish
Published PARIS Elsevier Masson SAS 01.05.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:N 4-Methyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4M, 1), N 4, N 4-dimethyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4DM, 2) and N 4-piperidyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4Pip, 3) and their copper(II) complexes [Cu(4NO 2Ac4M) 2] ( 4), [Cu(4NO 2Ac4DM) 2] ( 5) and [Cu(4NO 2Ac4Pip) 2] ( 6) were tested for their in vitro ability to inhibit the growth of Trypanosoma cruzi epimastigote forms. H4NO 2Ac4DM ( 2), [Cu(4NO 2Ac4M) 2] ( 4) and [Cu(4NO 2Ac4DM) 2] ( 5) proved to be as active as the clinical reference drugs nifurtimox and benznidazol. Taking into consideration the serious side effects and the poor efficacy of the reference drugs, as well as the appearance of resistance during treatment, the studied compounds could constitute a new class of anti-trypanosomal drug candidates. [Display omitted] N 4-Methyl- (H4NO 2Ac4M, 1), N 4, N 4-dimethyl- (H4NO 2Ac4DM, 2) and N 4-piperidyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4Pip, 3) and their copper(II) complexes [Cu(4NO 2Ac4M) 2] ( 4), [Cu(4NO 2Ac4DM) 2] ( 5) and [Cu(4NO 2Ac4Pip) 2] ( 6) were tested for their in vitro ability to inhibit the growth of Trypanosoma cruzi epimastigote forms. H4NO 2Ac4DM ( 2) as well as complexes 4 and 5 proved to be as active as the clinical reference drugs nifurtimox and benznidazol.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2007.06.020